Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study

Cesare Hassan, A Zullo, V De Francesco, G Scaccianoce, A Panarese, D Piglionica, C Panella, S Morini, E. Ierardi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

39 Citazioni (Scopus)

Abstract

Helicobacter pylori eradication rate with standard triple therapies is decreasing. Recently, lactoferrin administration has been shown to significantly increase the cure rate of 7-day rabeprazole, clarithromycin and tinidazole triple therapy. We assessed whether lactoferrin also increases the eradication rate of 7-day esomeprazole, clarithromycin and amoxycillin triple therapy as first-line treatment.
Lingua originaleEnglish
pagine (da-a)496-500
Numero di pagine5
RivistaDIGESTIVE AND LIVER DISEASE
Volume37
DOI
Stato di pubblicazionePubblicato - 2005
Pubblicato esternamenteYes

Keywords

  • Amoxicillin
  • Anti-Bacterial Agents
  • Clarithromycin
  • Drug Therapy, Combination
  • Dyspepsia
  • Helicobacter Infections
  • Helicobacter pylori
  • Humans
  • Lactoferrin
  • Prospective Studies

Fingerprint

Entra nei temi di ricerca di 'Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study'. Insieme formano una fingerprint unica.

Cita questo